Profile
Jeffrey M.
Besterman is currently a Member-Special Review Committee at the National Cancer Institute.
Previously, he worked as the CSO and Executive VP-Research & Development at Mirati Therapeutics, Inc. from 2012 to 2013.
He also worked as the Head-Cell Biology Department at GlaxoSmithKline Research & Development.
Besterman holds a doctorate degree from the University of Vermont and an undergraduate degree from The State University of New York.
Jeffrey M. Besterman active positions
| Companies | Position | Start |
|---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Former positions of Jeffrey M. Besterman
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2013-03-13 |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Education of Jeffrey M. Besterman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Jeffrey M. Besterman
















